Pfizer and BioNTech are currently paid $30.50 per COVID vaccine dose by the U.S. government. The price will skyrocket if the emergency declaration in the U.S. isn’t renewed next year.
Pfizer Inc. PFE, +4.08% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +8.33% for $110 to $130 per dose once the U.S. market for COVID-19 shots becomes commercial, likely in the first quarter of next year.
The emergency declaration in the U.S. isn’t expected to be renewed next year, which will lead to the formation of an official commercial market for COVID-19 vaccines, tests and treatments. That said, this change doesn’t mean most Americans will be on the hook to pay for their shots in 2023 and beyond.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Targets Covid Vaccine Price of at Least $110 a DosePfizer said it expects to price its Covid-19 vaccine at $110 to $130 a dose for adults when the U.S. government stops purchases
Read more »
FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or ModernaNovavax's Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.
Read more »
Labour board finds Sask. professor was wrongly disciplined over COVID-19 postsAn arbitrator has ruled that the University of Saskatchewan never should have sent a letter telling an outspoken faculty member to remove references to his employment from his social media accounts
Read more »
The City of Dallas May Offer Eviction Protections Beyond COVID-19 PandemicThe conditions under which Dallas’ COVID-19 eviction ordinance were created don’t really exist today. That's why the city is looking for a new ordinance.
Read more »
Whites now more likely to die from covid than Blacks: Why the pandemic shiftedAs the pandemic progressed, the damage done by the coronavirus broadened, and the toxicity of modern-day politics came to the fore.
Read more »